NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-192-2020-0-US-01 USE OF STING AGONISTS TO AUGMENT CAR T CELL FUNCTION IN SOLID TUMORS US 62/932,913 Abandoned
NCI E-494-2013-0-JP-13 Methods of Preparing Anti-human Papillomavirus Antigen T Cells JP DIV 2019-202239 Issued
NHLBI E-200-2018-0-US-03 COMPOSITIONS AND METHODS FOR TREATING BETA-GLOBINOPATHIES US ORD 16/676,369 11325978 Issued PDF
NHLBI E-200-2018-0-PCT-02 Treatment Of The Beta-globinopathies Through Inhibition Of RIOK3 Activity PCT PCT PCT/US2019/060151 Expired
NCI E-264-2011-0-EP-10 Delivery Of Packaged RNA To Mammalian Cells EP DIV 19207297.3 Issued
NCI E-069-2017-0-US-03 METHODS OF PREPARING A RE-USABLE SINGLE CELL AND METHODS FOR ANALYZING THE EPIGENOME, TRANSCRIPTOME, AND GENOME OF A SINGLE CELL US National Stage 16/611,098 11401544 Issued PDF
NCI E-079-2020-0-US-01 Immunotherapy With An Immuninotoxin and Immunostimulator US 62/927,753 Abandoned
NICHD E-138-2019-0-US-01 COMBINED PIKFYVE AND P38 MAP KINASE INHIBITION FOR TREATING CANCER US 62/927,966 Abandoned
NCI E-017-2017-0-AU-03 CHIMERIC ANTIGEN RECEPTORS AND THEIR USES AU National Stage 2018269194 Pending
NCI E-019-2014-2-US-03 COMPOUNDS THAT BIND TO HUMAN IMMUNODEFICIENCY VIRUS REV RESPONSE ELEMENT US CON 16/664,523 11692010 Issued PDF
NCATS E-198-2016-0-US-04 Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling US National Stage 16/608,489 11026947 Issued PDF
NCATS E-051-2020-0-PCT-02 Crystal Forms Of An ALK2 Inhibitor PCT PCT PCT/US2019/058062 Expired
NCI E-344-2013-0-AU-01 TEM8 Antibodies and Their Use AU DIV 2022200117 Issued
NHLBI E-152-2018-0-US-02 Fluorogen-binding RNA Aptamers US National Stage 16/608,127 11434490 Issued PDF
NCI E-344-2013-0-AU-17 TEM8 Antibodies and Their Use AU DIV 2019253864 Issued
NCATS E-262-2016-0-HK-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS HK EP 19131469.9 Abandoned
NCI E-166-2018-0-US-04 HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS US ORD 16/662,808 Issued
NCI E-166-2018-0-TW-03 HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS TW ORD 108138456 Issued
NCI E-166-2018-0-PCT-02 HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS PCT PCT PCT/US2019/057833 Expired
NCI E-520-2013-0-AU-09 HLA-A24 Agonist Epitopes Of MUC1-C Oncoprotein and Compositions and Methods of Use AU DIV 2019203443 Issued
NCI E-520-2013-0-JP-17 HLA-A24 Agonist Epitopes Of MUC1-C Oncoprotein and Compositions and Methods of Use JP DIV 2019-204306 Pending
NCI E-185-2019-0-US-01 High Affinity Nanobodies Targeting B7-H3 (CD276) For Treating Multiple Solid Tumors US 62/924,498 Abandoned
NIAID E-052-2017-4-US-47 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection US CON 16/659,426 11129905 Issued PDF
NCI E-160-2018-0-PCT-02 RECOMBINANT GP120 PROTEIN WITH V1-LOOP DELETION PCT PCT PCT/US2019/057268 Expired
NLM E-107-2010-2-US-29 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 16/658,195 Abandoned
NCI E-160-2018-0-EP-05 RECOMBINANT GP120 PROTEIN WITH V1-LOOP DELETION EP National Stage 19804901.7 Pending
NCI E-190-2014-0-JP-40 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF
TUMORS 		JP DIV 2019-191919 Abandoned
NHGRI E-177-2020-0-US-01 METHODS FOR TREATMENT OF SUBJECTS WITH PREEXISTING IMMUNITY TO VIRAL TRANSFER VECTORS US 62/624,103 Abandoned
NHGRI E-178-2020-0-US-01 METHODS FOR TREATMENT OF SUBJECTS WITH PREEXISTING IMMUNITY TO VIRAL TRANSFER VECTORS US 62/924,143 Abandoned
NCI E-160-2018-0-AU-03 RECOMBINANT GP120 PROTEIN WITH V1-LOOP DELETION AU National Stage 2019368218 Pending
NCI E-160-2018-0-CA-04 RECOMBINANT GP120 PROTEIN WITH V1-LOOP DELETION CA National Stage 3117390 Pending
NCI E-128-2017-0-US-04 DEVICE FOR STORING AND TRANSPORTING TISSUE SPECIMENS US National Stage 16/606,555 11623220 Issued PDF
NIAID E-187-2018-0-PCT-02 A HIGH-YIELD PERFUSION-BASED TRANSIENT GENE EXPRESSION BIOPROCESS PCT PCT PCT/US2019/057038 Expired
NIAID E-216-2018-2-PCT-01 Multi-Specific Antibodies For HIV-1 And Their Utility PCT PCT COMB PCT/US2019/057089 Expired
NIAID E-076-2015-4-US-01 METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION US DIV 16/655,516 11173201 Issued PDF
NHGRI E-092-2014-1-US-06 SIALYLATION-INCREASING THERAPIES FOR DISEASES ASSOCIATED WITH OXIDATIVE STRESS US DIV 16/655,004 Abandoned
NHGRI E-175-2019-0-US-01 Synthetic Genes For The Treatment Propionic Acidemia (PA) Caused By Mutations In Propionyl-coA Carboxylase Alpha (PCCB) US 62/915,347 Abandoned
NIA E-139-2012-2-US-14 METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES US CON 16/600,234 10772849 Issued PDF
NCATS E-022-2018-0-EP-06 COMPOSITIONS AND METHODS FOR CELL CULTURE EP National Stage 19797474.4 Pending
NCATS E-022-2018-0-JP-07 COMPOSITIONS AND METHODS FOR CELL CULTURE JP National Stage 2021-520118 Pending
NCATS E-022-2018-0-CA-05 COMPOSITIONS AND METHODS FOR CELL CULTURE CA National Stage 3116212 Pending
NCI E-174-2019-0-US-01 A VIRAL EXPOSURE SIGNATURE FOR DETECTION OF EARLY STAGE HEPATOCELLULAR CARCINOMA US 62/914,138 Abandoned
NCATS E-022-2018-0-PCT-02 COMPOSITIONS AND METHODS FOR CELL CULTURE PCT PCT PCT/US2019/055940 Expired
NCATS E-022-2018-0-AU-04 COMPOSITIONS AND METHODS FOR CELL CULTURE AU National Stage 2019359473 Pending
NCI E-106-2014-0-TW-18 YEAST-BASED IMMUNOTHERAPY FOR CHORDOMA TW DIV 108107386 Pending
NCI E-344-2013-0-EP-11 TEM8 ANTIBODIES AND THEIR USE EP DIV 19201975.0 Issued
NCI E-344-2013-0-FR-01 TEM8 ANTIBODIES AND THEIR USE FR EP 19201975.0 Issued
NCI E-344-2013-0-DE-01 TEM8 ANTIBODIES AND THEIR USE DE EP 19201975.0 Issued
NCI E-344-2013-0-ES-01 TEM8 ANTIBODIES AND THEIR USE ES EP 19201975.0 Issued
NCI E-344-2013-0-IT-01 TEM8 ANTIBODIES AND THEIR USE IT EP 19201975.0 Issued